We are live on ! Find out more
OLMA icon

Olema Pharmaceuticals
OLMA

128 hedge funds and large institutions have $626M invested in Olema Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 51 increasing their positions, 34 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

305% more call options, than puts

Call options by funds: $1.93M | Put options by funds: $477K

50% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 34

12% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 26

3.18% more ownership

Funds ownership: 100.34% → 103.52% (+3.2%)

2% more funds holding

Funds holding: 126 → 128 (+2)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

1% less capital invested

Capital invested by funds: $635M → $626M (-$8.72M)

Holders
128
Holders Change
+2
Holders Change %
+1.59%
% of All Funds
1.85%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
29
Increased
51
Reduced
34
Closed
26
Calls
$1.93M
Puts
$477K
Net Calls
+$1.46M
Net Calls Change
+$1.31M

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$34.8M
2
GPP
Great Point Partners
Connecticut
+$8.64M
3
BlackRock
BlackRock
New York
+$8.49M
4
DTC
Deep Track Capital
Connecticut
+$8.4M
5
CS
Candriam SCA
Luxembourg
+$7.65M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$13.3M
2
LGM
Logos Global Management
California
-$12.7M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$12.6M
4
B
Braidwell
Connecticut
-$7.97M
5
Citadel Advisors
Citadel Advisors
Florida
-$7.03M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$3.63M -$1.76M -162,555 -33%
Adage Capital Partners
27
Adage Capital Partners
Massachusetts
$3.52M -$1.46M -135,000 -29%
AAA
28
Affinity Asset Advisors
New York
$2.98M +$2.98M +275,000 New
Deutsche Bank
29
Deutsche Bank
Germany
$2.75M +$52.5K +4,844 +2%
HS
30
HighVista Strategies
Massachusetts
$2.68M – – –
SCM
31
Soleus Capital Management
Connecticut
$2.34M -$4.79M -441,500 -67%
AllianceBernstein
32
AllianceBernstein
Tennessee
$2.26M +$1.99M +183,493 +731%
Two Sigma Investments
33
Two Sigma Investments
New York
$1.97M +$936K +86,306 +90%
Schroder Investment Management Group
34
Schroder Investment Management Group
United Kingdom
$1.73M +$1.73M +159,739 New
UBS Group
35
UBS Group
Switzerland
$1.72M -$158K -14,536 -8%
NM
36
Newtyn Management
New York
$1.51M -$108K -10,000 -7%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$1.51M +$636K +58,622 +72%
Bank of America
38
Bank of America
North Carolina
$1.44M -$2.1M -193,424 -59%
Citadel Advisors
39
Citadel Advisors
Florida
$1.43M -$7.03M -648,407 -83%
Two Sigma Advisers
40
Two Sigma Advisers
New York
$1.4M -$206K -19,000 -13%
Charles Schwab
41
Charles Schwab
California
$1.33M +$393K +36,239 +42%
SAM
42
Sectoral Asset Management
Quebec, Canada
$1.28M -$233K -21,500 -15%
N
43
Nuveen
North Carolina
$1.28M +$190K +17,545 +17%
SSA
44
Schonfeld Strategic Advisors
New York
$1.27M -$942K -86,899 -43%
TI
45
Trexquant Investment
Connecticut
$1.24M +$1.24M +114,642 New
Rafferty Asset Management
46
Rafferty Asset Management
New York
$1.1M -$2.09M -192,713 -65%
Jacobs Levy Equity Management
47
Jacobs Levy Equity Management
New Jersey
$946K +$135K +12,478 +17%
HWAM
48
Hennion & Walsh Asset Management
New Jersey
$945K +$947K +87,312 New
UBS AM
49
UBS AM
Illinois
$904K +$594K +54,800 +190%
DIA
50
Dana Investment Advisors
Wisconsin
$808K +$810K +74,657 New
1
2
3 4 5

OLMA Hedge Fund Activity: Q2 2024 in Review

128 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Olema Pharmaceuticals (OLMA) for Q2 2024, worth a combined $626M — down 1.4% from $635M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new OLMA positions and 26 closed out — a net gain of 3 holders — while 51 added to existing stakes and 34 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $34.8M. The largest seller was State Street, cutting an estimated $13.3M.

  • 128 institutional investors held Olema Pharmaceuticals (OLMA) as of Q2 2024, up from 126 in Q1 2024.
  • Funds reported $626M of Olema Pharmaceuticals stock for Q2 2024, down 1.4% quarter-over-quarter.
  • 29 funds opened new Olema Pharmaceuticals positions in Q2 2024 and 26 closed out, a net change of +3 holders.
  • The largest Olema Pharmaceuticals buyer in Q2 2024 was Point72 Asset Management, an estimated $34.8M added.
  • The largest Olema Pharmaceuticals seller in Q2 2024 was State Street, an estimated $13.3M sold.

Based on aggregated 13F filings for Q2 2024.